4th Annual Genome Editing US Congress03 - 04 December 2020 | EST (UTC-5)

With gene editing tools becoming advanced enough to realise therapeutic potential, decision-makers working in academia and pharma are looking to leverage on the latest tools in drug development, therapeutic development and biotherapeutics production 

The NextGen Omics Series US includes...

Over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.

Over 80 case studies, solution & technology presentations and 2 interactive workshops over the 2 days.

Genome Editing - Agenda at a Glance

Day One

  • Genome Editing Technologies & Techniques
  • Drug Discovery & Development Applications
  • Regulation and Translation of Genome Editing in the Clinic

Day Two

  • Drug Discovery & Development – Target Identification and Validation
  • Genome Editing Technologies & Techniques in CHO Cell Engineering
  • Non-Human Models in Therapeutic Development

Live Webinar

FluidFM: a new approach
to CRISPR gene editing

Thursday, Mar 19 2020 | 1:00 PM - 2:00 PM GMT

hosted by Dr. Paul Monnier, Field Application Scientist
& Dr. Maria Milla, Life Sciences Application Scientist

Towards High Dimensional Sequencing: From Single-Cell to Spatial Omics

hosted by Andrea O'Hara, Technical Application Specialist, Genewiz & Zeng-jie Yang, Associate Professor Fox Chase Cancer Center

Taking place on day one of
NextGen Omics US: Virtual
@ 11:00 AM - 11:30 AM EST (UTC-5)